Article
Cells induced to express a human immunodeficiency virus type 1 envelope gene mutant inhibit the spread of wild-type virus.
Human gene therapy - 1 Aug 1992
Buchschacher G L, Freed E O, Panganiban A T
Abstract excerpt
The feasibility of using a trans-dominant interfering human immunodeficiency virus type 1 (HIV-1) envelope mutant for inducible gene therapy of HIV infection was investigated. Genes encoding wild-type or mutant glycoproteins were introduced into CD4+ cells, where they were stably maintained but not expressed until induced. Envelope (env) gene expression was dependent upon the viral regulatory protein Tat....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
